CoE-applicant from the Institute for cancer research to final round
H.A. Stenmark - proposed CoE director
In December 2006, between five and ten new centres of excellence will be selected by the Research Council. 26 of the total of 98 research groups that have applied for CoE-status from 2007 have reached the final selection round. Among the finalists is the application from the "Centre for Cancer Biomedicine" at Norwegian Radium Hospital, with Harald A. Stenmark as proposed CoE director. At present, there are 13 established Norwegian Centres of Excellence in all fields of science.
The Centres of Excellence (CoE) scheme, which is initiated by the Research Council of Norway, has the intention to bring more Norwegian researchers and research groups up to a high international standard. The centres are devoted to long-term, basic research.
From major journals, first or last author from the Institute for Cancer Research
Skourti E, Seip K, Mensali N, Jabeen S, Juell S, Øynebråten I, Pettersen S, Engebraaten O, Corthay A, Inderberg EM, Dolznig H, Mælandsmo GM, Egeland EV, Prasmickaite L(2025) Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer Breast Cancer Res, 27(1), 131 DOI 10.1186/s13058-025-02082-x, PubMed 40660361
Chen Y, He L, Ianevski A, Nader K, Ruokoranta T, Linnavirta N, Miettinen JJ, Vähä-Koskela M, Vänttinen I, Kuusanmäki H, Kontro M, Porkka K, Wennerberg K, Heckman CA, Giri AK, Aittokallio T(2025) A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia Cancer Res, 85(14), 2753-2768 DOI 10.1158/0008-5472.CAN-24-3840, PubMed 40354625
Skourti E, Seip K, Mensali N, Jabeen S, Juell S, Øynebråten I, Pettersen S, Engebraaten O, Corthay A, Inderberg EM, Dolznig H, Mælandsmo GM, Egeland EV, Prasmickaite L(2025) Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer Breast Cancer Res, 27(1), 131 DOI 10.1186/s13058-025-02082-x, PubMed 40660361